Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2D325F355Q
- Awardee
-
Chartwell RX LLC UEI ER5UA9TYBGH4
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $3,672
Award facts
- Contract value 100% obligated
- $3,671.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Congers, NY 10920, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,671.95 to Chartwell RX LLC on August 27, 2025, for the supply of Ondansetron ODT (orally disintegrating tablets) 4 mg in a quantity of 30 tablets. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and will be fulfilled from Chartwell RX's facility in Congers, New York. No set-aside designation was applied to this award. Ondansetron is a critical antiemetic medication widely used across military treatment facilities and federal healthcare systems to manage nausea and vomiting in various patient populations.
Chartwell RX LLC, a for-profit pharmaceutical manufacturer and distributor registered in the System for Award Management since April 2019, serves as the prime contractor on this award. The company has established a substantial presence in the federal pharmaceutical supply chain, holding multiple Indefinite Delivery Vehicle contracts with the Defense Logistics Agency and Department of Health and Human Services. Chartwell RX's contract portfolio includes several significant awards exceeding $40 million for pharmaceutical supply, reflecting its role as a reliable provider of critical medications to support military and government healthcare operations. This delivery order represents a routine fulfillment under the company's existing pharmaceutical supply agreements with federal agencies.
Quick answers
Who was awarded contract SPE2D325F355Q?
SPE2D325F355Q was awarded to Chartwell RX LLC by Medical Supply Chain (Troop Support) on August 27, 2025.
How much is contract SPE2D325F355Q worth?
The government has obligated $3,672 on SPE2D325F355Q.
Is contract SPE2D325F355Q an order under another contract?
Yes. SPE2D325F355Q is a delivery order under SPE2D020D0005, an indefinite delivery contract.
Was contract SPE2D325F355Q competed?
The extent of competition for SPE2D325F355Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award